Timpson, Texas earthquake updated to M4.8 (from M4.3) + I Felt It reports + shaking video Wastewater injection is seen as a major activity trigger. Even USGS is talking with a double tongue about the subject. Maybe, maybe … The area had also some historic quakes in a time fracking did not exist yet. The discussion will certainly go on. 05/18/2012 - 9:08 pm | View Link
I am one of the 10 million people who acquired an iPhone 6 or iPhone 6 Plus ten days ago. Coming from Planet Android, I wasn’t as put off by the larger dimensions as everyone else in the technosphere seemed to be. But I was, as usual, put off by one thing that both the Apple product and its archnemesis from Google shared: the unpocketability of the phone, particularly by females.
Christian Science MonitorCrisis averted? Afghanistan, US sign security pactChristian Science MonitorThe pact, along with a similar deal between NATO and Afghanistan, will allow Western troops to stay in Afghanistan past the end of this year. It also means that foreign aid can resume flowing into Afghanistan – a critical need for the country.
About 10 years after he first started studying the causes of heart disease, Jerry Morris started to jog. “I was the first person to run on Hampstead Heath, in the 1960s," he'd later tell The Financial Times: Every Sunday morning, if the weather was at all possible, I took off my coat, and my little boy carried my coat, I took off my jacket and my little girl carried my jacket, and I ran for 20 minutes.
In Atlanta this week, opening arguments are underway in a racketeering trial where prosecutors will argue that public school educators engaged in a massive conspiracy to cheat on high-stakes tests. From the Atlanta Journal-Constitution’s coverage of Monday’s opening arguments: “This conspiracy was cleverly, cleverly disguised and the purpose of the conspiracy was this—to illegally inflate test scores and create a false, false impression of academic success for many students in the Atlanta Public School system,” said prosecutor Fani Willis.
New York TimesJ&J Gains Viral Therapies in $1.75 Billion Alios AcquisitionBusinessweekJohnson & Johnson (JNJ:US), the biggest maker of consumer health products, said it will acquire Alios BioPharma Inc., a developer of viral disease therapies. J&J will pay $1.75 billion in cash for closely held Alios, according to a statement today.